The Prolactin Inducible Protein Modulates Antitumor Immune Responses and Metastasis in a Mouse Model of Triple Negative Breast Cancer

The prolactin inducible protein (PIP) is expressed to varying degrees in more than 90% of breast cancers (BCs). Although high levels of PIP expression in BC has been shown to correlate with better prognosis and patient response to chemotherapy, some studies suggest that PIP may also play a role in m...

Descripción completa

Detalles Bibliográficos
Autores principales: Edechi, Chidalu A., Ikeogu, Nnamdi M., Akaluka, Gloria N., Terceiro, Lucas E. L., Machado, Mikayla, Salako, Enitan S., Barazandeh, Aida F., Kung, Sam K. P., Uzonna, Jude E., Myal, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994859/
https://www.ncbi.nlm.nih.gov/pubmed/33777801
http://dx.doi.org/10.3389/fonc.2021.639859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994859/
https://www.ncbi.nlm.nih.gov/pubmed/33777801
http://dx.doi.org/10.3389/fonc.2021.639859

Ejemplares similares